Home » THE ANTIHYPERTENSIVE MARKET IS EXPECTED TO EXCEED $50BN BY 2014 ACROSS THE SEVEN MAJOR MARKETS
THE ANTIHYPERTENSIVE MARKET IS EXPECTED TO EXCEED $50BN BY 2014 ACROSS THE SEVEN MAJOR MARKETS
Research and Markets has announced the addition of Antihypertensives
Two Years to Shape the Market? to their offering. The antihypertensive market
is expected to exceed $50bn by 2014 across the seven major markets, with novel
treatments and the market-leading ARBs delivering much of this value. However,
significant hurdles exist, and pharmaceutical companies need to be savvy regarding
marketing and pricing structures for their products, as only the most cunning
and aggressive companies look set to survive.
Genetic
Engineering News
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
28Mar
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May